A recent analysis reveals the safety profile of once-nightly sodium oxybate for narcolepsy, highlighting low discontinuation rates and common adverse events.:
Source: Neurology Read More
Post-Hoc Analysis Gives Safety Insights on Switch From Twice-Nightly Oxybate to Once-Nightly Treatment
Related Posts
<![CDATA[Advancing Neuromuscular Research Through
Collaboration and Patient-Centered Perspectives: Łukasz Sznajder,
PhD, MSc]]>
<![CDATA[Advancing Neuromuscular Research Through Collaboration and Patient-Centered Perspectives: Łukasz Sznajder, PhD, MSc]]>
